Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 10:06 am Purchase | 2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | RTW INVESTMENTS LP | 3,354,303 7.200% | 90,272 (+2.77%) | Filing History |
| 2023-02-14 10:05 am Purchase | 2022-12-31 | 13G | Oyster Point Pharma, Inc. OYST | RTW INVESTMENTS LP | 2,304,977 8.600% | 246,473 (+11.97%) | Filing History |
| 2023-02-14 10:05 am Purchase | 2022-10-31 | 13G | Immunocore Holdings plc IMCR | RTW INVESTMENTS LP | 5,559,322 12.300% | 5,559,322 (New Position) | Filing History |
| 2023-02-14 10:04 am Purchase | 2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LP | 4,993,279 9.600% | 1,126,407 (+29.13%) | Filing History |
| 2023-02-14 10:04 am Purchase | 2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | RTW INVESTMENTS LP | 3,591,986 7.300% | 992,164 (+38.16%) | Filing History |
| 2023-02-14 10:04 am Sale | 2022-12-31 | 13G | ESSA Pharma Inc. EPIX | RTW INVESTMENTS LP | 0 0.000% | -2,637,192 (Position Closed) | Filing History |
| 2023-02-14 10:03 am Purchase | 2022-12-31 | 13G | Establishment Labs Holdings Inc. ESTA | RTW INVESTMENTS LP | 2,374,138 9.800% | 55,000 (+2.37%) | Filing History |
| 2023-02-14 10:02 am Purchase | 2022-12-31 | 13G | PTC Therapeutics, Inc. PTCT | RTW INVESTMENTS LP | 5,615,387 7.700% | 321,421 (+6.07%) | Filing History |
| 2023-02-14 10:02 am Purchase | 2022-12-31 | 13G | CUTERA INC CUTRQ | RTW INVESTMENTS LP | 1,798,675 9.200% | 401,612 (+28.75%) | Filing History |
| 2023-02-14 10:01 am Sale | 2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | RTW INVESTMENTS LP | 5,741,939 9.300% | -68,201 (-1.17%) | Filing History |
| 2023-02-14 10:01 am Purchase | 2022-12-31 | 13G | Exagen Inc. XGN | RTW INVESTMENTS LP | 1,364,336 8.400% | 542,922 (+66.10%) | Filing History |
| 2023-02-14 10:01 am Purchase | 2022-12-31 | 13G | Adicet Bio, Inc. ACET | RTW INVESTMENTS LP | 4,241,472 9.900% | 1,217,728 (+40.27%) | Filing History |
| 2023-02-14 10:00 am Sale | 2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS | RTW INVESTMENTS LP | 0 0.000% | -2,120,760 (Position Closed) | Filing History |
| 2023-02-02 4:15 pm Purchase | 2022-09-01 | 13D | Avidity Biosciences, Inc. RNA | RTW INVESTMENTS LP | 5,956,558 9.000% | 1,961,558 (+49.10%) | Filing History |
| 2023-01-27 5:10 pm Purchase | 2022-01-24 | 13D | Orchestra BioMed Holdings, Inc. OBIO | RTW INVESTMENTS LP | 5,118,512 16.200% | 5,118,512 (New Position) | Filing History |
| 2022-12-05 4:09 pm Sale | 2021-12-31 | 13G | Immunovant, Inc. IMVT | RTW INVESTMENTS LP | 0 0.000% | -8,459,241 (Position Closed) | Filing History |
| 2022-12-02 4:06 pm Purchase | 2020-12-31 | 13G | Immunovant, Inc. IMVT | RTW INVESTMENTS LP | 8,459,241 6.540% | 866,988 (+11.42%) | Filing History |
| 2022-11-08 4:56 pm Sale | 2022-11-04 | 13D | DermTech, Inc. DMTKQ | RTW INVESTMENTS LP | 3,018,666 9.990% | -100,000 (-3.21%) | Filing History |
| 2022-11-03 4:15 pm Sale | 2022-11-01 | 13D | Landos Biopharma, Inc. LABP | RTW INVESTMENTS LP | 0 0.000% | -315,072 (Position Closed) | Filing History |
| 2022-10-31 5:05 pm Sale | 2022-10-27 | 13D | Landos Biopharma, Inc. LABP | RTW INVESTMENTS LP | 315,072 7.830% | -50,000 (-13.70%) | Filing History |